Protocol summary

Study aim
Comparing the effects of remifentanil with fentanyl on pain intensity, hemodynamic status and post-anesthesia complications of cataract surgery candidate
Design
This study will be conducted as a randomized clinical trial (blocks of four), double-blind, with parallel groups, without a control group, and phase 2-3, with the participation of 80 patients.
Settings and conduct
This study is a randomized clinical trial (blocks of four), double-blind (participants and results analyzer), with parallel groups, without a control group and phase 2-3 and with the participation of 80 ERCP candidates referred to Imam Reza Hospital (Tabriz) will be done.
Participants/Inclusion and exclusion criteria
The criteria for entering the study include: ASA class I and II , candidates for cataract surgery and consent to participate in the study, and the exclusion criteria are: having diabetes or other endocrine disorders and using painkillers in the last 24 hours.
Intervention groups
In the fentanyl group (group B), induction with 1 mg of midazolam, 0.7 micrograms per kilogram of body weight of fentanyl, 1 to 2 mg per kilogram of body weight of propofol along with 1 mg per kilogram of the patient's body weight Lidocaine and finally 10 mg of atracurium will be injected. In the remifentanil group (group A), induction with 1 mg of midazolam, 2 to 4 micrograms per kilogram of body weight of remifentanil, 1 to 2 mg per kilogram of body weight of propofol along with 1 mg per kilogram of body weight Lidocaine will be injected into the patient's body. Then, the speed of the onset of anesthesia and the complications after the surgery will be recorded in recovery.
Main outcome variables
Pain

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20190325043107N35
Registration date: 2023-09-01, 1402/06/10
Registration timing: prospective

Last update: 2023-09-01, 1402/06/10
Update count: 0
Registration date
2023-09-01, 1402/06/10
Registrant information
Name
Mehdi Khanbabayi Gol
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 41 3334 7054
Email address
khanbabayimehdi69@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2023-09-20, 1402/06/29
Expected recruitment end date
2023-11-20, 1402/08/29
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparing the effects of remifentanil with fentanyl on pain intensity, hemodynamic status and post-anesthesia complications of cataract surgery candidate
Public title
Efects of remifentanil with fentanyl on pain intensity, hemodynamic status and post-anesthesia complications
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:
ASA class I and II Candidate for cataract surgery Consent to participate in the study
Exclusion criteria:
Having diabetes or other endocrine disorders Use of painkillers in the last 24 hours
Age
From 18 years old to 65 years old
Gender
Both
Phase
2-3
Groups that have been masked
  • Participant
  • Data analyser
Sample size
Target sample size: 80
Randomization (investigator's opinion)
Randomized
Randomization description
In this study, with a sample size of 80, we use the patients using the block permutation randomization method, which is used in this method to balance the number of allocated samples, and with 4 people in each block. We assemble the possible blocks as follows. block 1: BBAA, block 2: AABB, block 3: ABAB, block 4: BABA, block 5: ABBA, and block 6: BAAB, we need 20 blocks for 80 people. It is random in the block method. We choose numbers from one to six. For example, if number 6 is chosen as the first block and number 2 as the second block, the people who enter the study will be given BAABAABB in order from left to right. and finally they were divided into two intervention groups (group A) and control group (group B).
Blinding (investigator's opinion)
Double blinded
Blinding description
The statistical consultant and the patient will be unaware of the type of grouping in this plan; The final results will be delivered to the statistical consultant. Since the statistical consultant and the patients will not be aware of the grouping of the participants; Therefore, they are blind during the study.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Tabriz University of Medical Sciences
Street address
Imam Reza Hospital, Azadi Ave
City
Tabriz
Province
East Azarbaijan
Postal code
5165665631
Approval date
2023-08-22, 1402/05/31
Ethics committee reference number
225

Health conditions studied

1

Description of health condition studied
Pain
ICD-10 code
G89.11
ICD-10 code description
Acute pain due to trauma

Primary outcomes

1

Description
Pain
Timepoint
Once every hour and for six hours after the end of anesthesia
Method of measurement
Visual Analog Scale

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: In the remifentanil group (group A), induction with 1 mg of midazolam, 2 to 4 micrograms per kilogram of body weight of remifentanil, 1 to 2 mg per kilogram of body weight of propofol along with 1 mg per kilogram of body weight Lidocaine will be injected into the patient's body. Then, the speed of the onset of anesthesia and the complications after the surgery will be recorded in recovery.
Category
Prevention

2

Description
Control group: In the fentanyl group (group B), induction with 1 mg of midazolam, 0.7 micrograms per kilogram of body weight of fentanyl, 1 to 2 mg per kilogram of body weight of propofol along with 1 mg per kilogram of the patient's body weight Lidocaine and finally 10 mg of atracurium will be injected. Then, the speed of the onset of anesthesia and the complications after the surgery will be recorded in recovery.
Category
Prevention

Recruitment centers

1

Recruitment center
Name of recruitment center
Imam Reza Hospital
Full name of responsible person
Mehdi Nazari
Street address
Imam Reza Hospital, Azadi Ave
City
Tabriz
Province
East Azarbaijan
Postal code
6165665631
Phone
+98 41 3335 5921
Email
mkhanbabayi@yahoo.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Tabriz University of Medical Sciences
Full name of responsible person
Abolghasem Jouyban
Street address
Imam Reza Hospital, Azadi Ave
City
Tabriz
Province
East Azarbaijan
Postal code
5165665631
Phone
+98 41 3335 7310
Email
Ajouyban@hotmail.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Tabriz University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Tabriz University of Medical Sciences
Full name of responsible person
Mehdi Khanbabayi Gol
Position
MSc in Nursing Education
Latest degree
Master
Other areas of specialty/work
Nursery
Street address
Imam Reza Hospital, Azadi Ave
City
Tabriz
Province
East Azarbaijan
Postal code
5981764863
Phone
+98 41 3334 7054
Fax
Email
Khanbabayimehdi69@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Tabriz University of Medical Sciences
Full name of responsible person
Mehdi Khanbabayi Gol
Position
MSc in Nursing Education
Latest degree
Master
Other areas of specialty/work
Nursery
Street address
Imam Reza Hospital, Azadi Ave
City
Tabriz
Province
East Azarbaijan
Postal code
5981764863
Phone
+98 41 3334 7054
Fax
Email
Khanbabayimehdi69@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Tabriz University of Medical Sciences
Full name of responsible person
Mehdi Khanbabayi Gol
Position
MSc in Nursing Education
Latest degree
Master
Other areas of specialty/work
Nursery
Street address
Imam Reza Hospital, Azadi Ave
City
Tabriz
Province
East Azarbaijan
Postal code
5981764863
Phone
+98 41 3334 7054
Fax
Email
Khanbabayimehdi69@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...